Using our proprietary CALM™ bio-sensing platform,  GTcardio continuously monitors key hemodynamics indicators,  including blood pressure, Sp02 and cardiac output,  to provide a complete view of the dynamics of blood circulation. 

​

GTcardio's technology is based on single-site photoplethysmography (PPG) readings, which involves measuring the volumetric pulsations of blood in tissue; these pulsations are associated with the arterial pressure pulse. PPG readings can be integrated into wearable devices. 

 

This technology can be used in a variety of clinical settings, including intensive care units, emergency departments, outpatient clinics or general wellness. – We are researching its applicability across multiple fields including longevity, neurodegenerative diseases (Alzheimer's), chronic diseases, and metabolic disorders (diabetes).